Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle Breastfeeding
Nutrients from the food that you eat passes to your breast milk. Its good idea to take healthy diet while breastfeeding. You may need to consume more calories per day to support healthy body system. Some time it gets necessary take medicine while you are breastfeeding and as other food items passes into breast milk, medicine passes as well hence it becomes obvious to understand its effects while breastfeeding. We have analyzed many medications and in this sheet we will present some fact and known information associated with Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle while breast-feeding.

What is Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle used for?


1. INDICATIONS AND USAGE Omeprazole delayed-release capsules, USP, are a proton pump inhibitor (PPI) indicated for the: Treatment of active duodenal ulcer in adults ( 1.1) Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults ( 1.2) Treatment of active benign gastric ulcer in adults ( 1.3) Treatment of symptomatic gastroesophageal reflux disease (GERD) in patients 2 years of age and older ( 1.4) Treatment of erosive esophagitis (EE) due to acid-mediated GERD in patients 2 years of age and older ( 1.5) Maintenance of healing of EE due to acid-mediated GERD in patients 2 years of age and older ( 1.6) Pathologic hypersecretory conditions in adults ( 1.7) 1.1 Treatment of Active Duodenal Ulcer Omeprazole delayed-release capsules, USP, are indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy. 1.2 Helicobacter pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence. Triple Therapy Omeprazole delayed-release capsules in combination with clarithromycin and amoxicillin, is indicated for treatment of patients with H. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate H. pylori in adults. Dual Therapy Omeprazole delayed-release capsules in combination with clarithromycin are indicated for treatment of patients with H. pylori infection and duodenal ulcer disease to eradicate H. pylori in adults. Among patients who fail therapy, Omeprazole delayed-release capsules with clarithromycin are more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. In patients who fail therapy, susceptibility testing should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is not possible, alternative antimicrobial therapy should be instituted [see Clinical Pharmacology (12.4) and the clarithromycin prescribing information, Microbiology section ]. 1.3 Treatment of Active Benign Gastric Ulcer Omeprazole delayed-release capsules are indicated for short-term treatment (4 to 8 weeks) of active benign gastric ulcer in adults. 1.4 Treatment of Symptomatic Gastroesophageal Reflux Disease (GERD) Omeprazole is indicated for the treatment of heartburn and other symptoms associated with GERD for up to 4 weeks in patients 2 years of age and older. 1.5 Treatment of Erosive Esophagitis (EE) Due to Acid-Mediated GERD Pediatric Patients 2 Years of Age to Adults Omeprazole is indicated for the short-term treatment (4 to 8 weeks) of EE due to acid-mediated GERD that has been diagnosed by endoscopy in patients 2 years of age and older. The efficacy of omeprazole used for longer than 8 weeks in patients with EE has not been established. If a patient does not respond to 8 weeks of treatment, an additional 4 weeks of treatment may be given. If there is recurrence of EE or GERD symptoms (e.g., heartburn), additional 4 to 8 week courses of Omeprazole may be considered. 1.6 Maintenance of Healing of EE Due to Acid-Mediated GERD Omeprazole is indicated for the maintenance healing of EE due to acid-mediated GERD in patients 2 years of age and older. Controlled studies do not extend beyond 12 months. 1.7 Pathological Hypersecretory Conditions Omeprazole is indicated for the long-term treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine adenomas and systemic mastocytosis) in adults.

Is using Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle safe or dangerous while breastfeeding?

Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle safe for breastfeeding
Omeprazole is the only one ingredient used in manufacturing of Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Omeprazole it is safe to use Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle while lactating. We suggest you to check further details below about Omeprazole usage in breastfeeding.

Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle Breastfeeding Analsys


Omeprazole while Breastfeeding

Safe

CAS Number: 73590-58-6

High plasma protein binding makes excretion into breast milk to be insignificant. No side effects were observed in breastfed infants of treated mothers. Shown to be labile in acid-pH environment must be administered in the form of micro-granules within an enteric-coated capsule. Any small quantity reaching the infant's stomach would be readily inactivated. Hyperprolactinemia and Galactorrhea have been reported.


Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle Breastfeeding Analsys - 2


Omeprazole while Breastfeeding

CAS Number: 73590-58-6

Limited information indicates that maternal omeprazole doses of 20 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants.



I am nursing mother and I have already used Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle, what should I do?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle and have used it then do not panic as Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle is mostly safe in breastfeeding and should not cause any harm to your baby.


My doctor has prescribed me Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle, what should I do?

Usage of Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle is safe for nursing mothers and baby, No worries.


If I am using Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Omeprazole by Aphena Pharma Solutions - Tennessee, Llc 90 In 1 Bottle in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week